John Townsend
Patrimonio netto: - $ in data 30/06/2026
Patrimonio netto: - $ in data 30/06/2026
John W.
Townsend is Chief Financial Officer at Unicycive Therapeutics, Inc. since 2021.
Formerly, Mr. Townsend was Chief Accounting Officer at Plus Therapeutics, Inc. in 2015.
From 2017 to 2020, Mr. Townsend was Chief Accounting Officer & Controller at Guardion Health Sciences, Inc. Mr. Townsend completed an undergraduate degree at San Diego State University in 1993.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/03/2021 |
| Società | Posizione | Fine |
|---|---|---|
| GUARDION HEALTH SCIENCES, INC. | Comptroller/Controller/Auditor | 02/09/2020 |
| PLUS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/06/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. Pharmaceuticals: OtherHealth Technology Develops and distributes food & dietary supplements | Health Technology |
Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale